Evoke Pharma Assets & Liabilities Overview 2012-2023 | EVOK

Evoke Pharma assets & liabilities overview from 2012 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Evoke Pharma Annual Assets & Liabilities Overview
(Millions of US $)
Evoke Pharma Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.835B 18.71
Aspen Pharmacare (APNHY) South Africa $4.900B 0.00
BridgeBio Pharma (BBIO) United States $4.401B 0.00
Bausch Health Cos (BHC) Canada $3.128B 2.44
Amphastar Pharmaceuticals (AMPH) United States $2.004B 13.71
Supernus Pharmaceuticals (SUPN) United States $1.656B 0.00
Taysha Gene Therapies (TSHA) United States $0.439B 0.00
Generation Bio (GBIO) United States $0.199B 0.00
Assembly Biosciences (ASMB) United States $0.074B 0.00
Personalis (PSNL) United States $0.066B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Teligent (TLGT) United States $0.000B 0.00